These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 29120273)
1. Triple Therapy in COPD: What We Know and What We Don't. Calverley PMA; Magnussen H; Miravitlles M; Wedzicha JA COPD; 2017 Dec; 14(6):648-662. PubMed ID: 29120273 [TBL] [Abstract][Full Text] [Related]
2. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019 [TBL] [Abstract][Full Text] [Related]
3. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
4. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study. Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047 [TBL] [Abstract][Full Text] [Related]
5. Stepwise management of COPD: What is next after bronchodilation? Miravitlles M; Matsunaga K; Dreher M Ther Adv Respir Dis; 2023; 17():17534666231208630. PubMed ID: 37936381 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study. Monteagudo M; Nuñez A; Barrecheguren M; Miravitlles M Arch Bronconeumol; 2022 Oct; 58(10):699-707. PubMed ID: 35618580 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
8. A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. Miravitlles M; Verhamme K; Calverley PMA; Dreher M; Bayer V; Gardev A; de la Hoz A; Wedzicha J; Price D Int J Chron Obstruct Pulmon Dis; 2022; 17():545-558. PubMed ID: 35309285 [TBL] [Abstract][Full Text] [Related]
9. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. D'Urzo A; Donohue JF; Kardos P; Miravitlles M; Price D Expert Opin Pharmacother; 2015; 16(12):1845-60. PubMed ID: 26194213 [TBL] [Abstract][Full Text] [Related]
10. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal. Vanfleteren L; Fabbri LM; Papi A; Petruzzelli S; Celli B Int J Chron Obstruct Pulmon Dis; 2018; 13():3971-3981. PubMed ID: 30587953 [TBL] [Abstract][Full Text] [Related]
11. DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach. Singh D; Litewka D; Páramo R; Rendon A; Sayiner A; Tanni SE; Acharya S; Aggarwal B; Ismaila AS; Sharma R; Daley-Yates P Adv Ther; 2023 Oct; 40(10):4282-4297. PubMed ID: 37382864 [TBL] [Abstract][Full Text] [Related]
12. Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality. Suissa S; Dell'Aniello S; Ernst P COPD; 2022 Dec; 19(1):1-9. PubMed ID: 34544314 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Nici L; Mammen MJ; Charbek E; Alexander PE; Au DH; Boyd CM; Criner GJ; Donaldson GC; Dreher M; Fan VS; Gershon AS; Han MK; Krishnan JA; Martinez FJ; Meek PM; Morgan M; Polkey MI; Puhan MA; Sadatsafavi M; Sin DD; Washko GR; Wedzicha JA; Aaron SD Am J Respir Crit Care Med; 2020 May; 201(9):e56-e69. PubMed ID: 32283960 [No Abstract] [Full Text] [Related]
15. Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? Kaplan AG J Am Board Fam Med; 2020; 33(2):289-302. PubMed ID: 32179613 [TBL] [Abstract][Full Text] [Related]
16. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939 [TBL] [Abstract][Full Text] [Related]
17. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study. Bloom CI; Douglas I; Usmani OS; Quint JK Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379 [TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm. Wilkie M; Finch S; Schembri S COPD; 2015; 12(5):582-90. PubMed ID: 25774769 [TBL] [Abstract][Full Text] [Related]
19. Triple inhaled therapy for chronic obstructive pulmonary disease. Montuschi P; Malerba M; Macis G; Mores N; Santini G Drug Discov Today; 2016 Nov; 21(11):1820-1827. PubMed ID: 27452453 [TBL] [Abstract][Full Text] [Related]
20. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline. Mammen MJ; Pai V; Aaron SD; Nici L; Alhazzani W; Alexander PE Ann Am Thorac Soc; 2020 Sep; 17(9):1133-1143. PubMed ID: 32530702 [No Abstract] [Full Text] [Related] [Next] [New Search]